Cavα2δ1&NET-IN-3结构式
|
常用名 | Cavα2δ1&NET-IN-3 | 英文名 | Cavα2δ1&NET-IN-3 |
|---|---|---|---|---|
| CAS号 | 2143584-82-9 | 分子量 | 466.60 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C24H30N6O2S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
Cavα2δ1&NET-IN-3用途Cavα2δ1和NET-IN-3(实施例216)是电压门控钙通道(VGCC)和去甲肾上腺素转运蛋白(NET)亚基α2δ的抑制剂。Cavα2δ1和NET-IN-3对Cav2.2钙通道和NET的人α2δ-1亚基的Kis分别为100-500nM[1]。 |
| 英文名 | Cavα2δ1&NET-IN-3 |
|---|
| 描述 | Cavα2δ1和NET-IN-3(实施例216)是电压门控钙通道(VGCC)和去甲肾上腺素转运蛋白(NET)亚基α2δ的抑制剂。Cavα2δ1和NET-IN-3对Cav2.2钙通道和NET的人α2δ-1亚基的Kis分别为100-500nM[1]。 |
|---|---|
| 相关类别 | |
| 靶点实验 |
Calcium Channel |
| 参考文献 |
| 分子式 | C24H30N6O2S |
|---|---|
| 分子量 | 466.60 |
|
实验名称:Displacement of [3H]-nisoxetine from human NET expressed in HEK293 cell membranes inc...
来源:ChEMBL
靶标:Sodium-dependent noradrenaline transporter
External Id:CHEMBL4714158
|
|
实验名称:Inhibition of human NET expressed in HEK293 cells assessed as reduction in ASP+ uptak...
来源:ChEMBL
靶标:Sodium-dependent noradrenaline transporter
External Id:CHEMBL4714159
|
|
实验名称:Displacement of [3H]-gabapentin from human Cav alpha2delta1 expressed in CHO-K1 cell ...
来源:ChEMBL
靶标:Voltage-dependent calcium channel subunit alpha-2/delta-1
External Id:CHEMBL4714156
|
|
实验名称:Binding Assay from US Patent US10590140: "Tetrahydropyrimidodiazepine and dihydropyri...
来源:BindingDB
靶标:N/A
External Id:BindingDB_9039_2
|
|
实验名称:Binding Assay from US Patent US10590140: "Tetrahydropyrimidodiazepine and dihydropyri...
来源:BindingDB
靶标:N/A
External Id:BindingDB_9039_1
|